Most TRPC6 mutants are characterized to have GOF phenotype; they elevate the cytosolic Ca2+, and subsequently cause cell death and/or cytoskeleton disorganization of podocytes, resulting in FSGS. The gene discussed is TRPC6; the disease is focal segmental glomerulosclerosis.